The effects of the gut bacterial product, gassericin A, on obesity in mice
Abstract Background Obesity can arise from various physiological disorders. This research examined the impacts of the bacteriocin, gassericin A, which is generated by certain gut bacteria, using an in vivo model of obesity. Methods Fifty Swiss NIH mice were randomly assigned to five different groups...
Saved in:
Main Authors: | Valeh Mahdavi, Hamid Reza Kazerani, Fereidoun Taghizad, Hedyeh Balaei |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12944-024-02423-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review
by: Aref Yarahmadi, et al.
Published: (2024-12-01) -
High-dose thiamine supplementation ameliorates obesity induced by a high-fat and high-fructose diet in mice by reshaping gut microbiota
by: Yu Xia, et al.
Published: (2025-02-01) -
Astragalin and rutin restore gut microbiota dysbiosis, alleviate obesity and insulin resistance in high-fat diet-fed C57BL/6J mice
by: Muni Swamy Ganjayi, et al.
Published: (2024-11-01) -
Orlistat ameliorates lipid dysmetabolism in high-fat diet-induced mice via gut microbiota modulation
by: Chengyan Huang, et al.
Published: (2025-02-01) -
Pregnancy Complications and Outcomes in Obese Women with Gestational Diabetes
by: Gitana Ramonienė, et al.
Published: (2025-01-01)